These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1808636)

  • 21. Staging and therapy of cryptogenic fibrosing alveolitis.
    Turner-Warwick M
    Chest; 1986 Mar; 89(3 Suppl):148S-150S. PubMed ID: 3948577
    [No Abstract]   [Full Text] [Related]  

  • 22. [A rare complication of sarcoidosis: pulmonary cavitation].
    Cavallo A; Perin B; Perini L; Natale F
    Radiol Med; 1987 Jun; 73(6):589-90. PubMed ID: 3602489
    [No Abstract]   [Full Text] [Related]  

  • 23. CT attenuation values of lung density in sarcoidosis.
    Gilman MJ; Laurens RG; Somogyi JW; Honig EG
    J Comput Assist Tomogr; 1983 Jun; 7(3):407-10. PubMed ID: 6841700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of high resolution computed tomography in the diagnosis of interstitial lung disease.
    Hansell DM; Kerr IH
    Thorax; 1991 Feb; 46(2):77-84. PubMed ID: 2014506
    [No Abstract]   [Full Text] [Related]  

  • 25. Gallium-67 scintigraphy, bronchoalveolar lavage, and pathologic changes in patients with pulmonary sarcoidosis.
    Abe S; Munakata M; Nishimura M; Tsuneta Y; Terai T; Nakano I; Ohsaki Y; Kawakami Y
    Chest; 1984 May; 85(5):650-5. PubMed ID: 6325097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The morphogenesis and classification of diffuse interstitial lung diseases: a clinicopathological approach, based on tissue reaction patterns.
    Henderson DW
    Aust N Z J Med; 1984 Oct; 14(5 Suppl 3):735-48. PubMed ID: 6598040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cryptogenic fibrosing alveolitis: pattern of disease in the lung.
    Wright PH; Buxton-Thomas M; Kreel L; Steel SJ
    Thorax; 1984 Nov; 39(11):857-61. PubMed ID: 6505992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A method for absolute quantification of 67Ga-citrate accumulation in the lungs and its significance in the evaluation of pulmonary sarcoidosis activity].
    Myslivecek M; Kolek V; Husák V; Hobza J; Knápek V; Erban J; Kleinbauer K
    Cesk Radiol; 1988 May; 42(3):210-20. PubMed ID: 3165055
    [No Abstract]   [Full Text] [Related]  

  • 29. Structural features of interstitial lung disease in systemic sclerosis.
    Harrison NK; Myers AR; Corrin B; Soosay G; Dewar A; Black CM; Du Bois RM; Turner-Warwick M
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):706-13. PubMed ID: 1892314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of interlobar variation of bronchoalveolar lavage cellular differentials in interstitial lung diseases.
    Garcia JG; Wolven RG; Garcia PL; Keogh BA
    Am Rev Respir Dis; 1986 Mar; 133(3):444-9. PubMed ID: 3954253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pulmonary biopsy in interstitial pneumopathies].
    Kuffer T; Kapanci Y
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1908-11. PubMed ID: 6977183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tc-99m erythromycin lactobionate inhalation scintigraphy in parenchymal lung diseases.
    Durak H; Aktoğu S; Değirmenci B; Sayit E; Ertay T; Dereli S
    Nucl Med Biol; 1999 Aug; 26(6):695-8. PubMed ID: 10587109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases.
    Prior C; Haslam PL
    Clin Exp Immunol; 1992 May; 88(2):280-7. PubMed ID: 1572093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cell differentiation in bronchoalveolar lavage in interstitial lung diseases--studies of sensitivity and specificity].
    Kanzow G; Stutz P; Magnussen H
    Prax Klin Pneumol; 1988 Mar; 42(3):92-5. PubMed ID: 3375197
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical significance of gallium-67 scintigraphy in assessing pulmonary lesions of sarcoidosis and idiopathic pulmonary fibrosis].
    Fujishima S; Kanazawa M; Yamasawa F; Kubo A; Hashimoto S; Yokoyama T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Mar; 30(3):435-40. PubMed ID: 1569722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computed tomography in chronic interstitial lung disease.
    Müller NL
    Radiol Clin North Am; 1991 Sep; 29(5):1085-93. PubMed ID: 1871257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proliferating alveolar macrophages in BAL and lung function changes in interstitial lung disease.
    Pforte A; Gerth C; Voss A; Beer B; Häussinger K; Jütting U; Burger G; Ziegler-Heitbrock HW
    Eur Respir J; 1993 Jul; 6(7):951-5. PubMed ID: 8370443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 51-1974.
    N Engl J Med; 1974 Dec; 291(26):1402-8. PubMed ID: 4427645
    [No Abstract]   [Full Text] [Related]  

  • 39. [Possibilities and limitations of bronchoalveolar lavage (BAL) in the cytologic evaluation of interstitial changes of the lungs].
    Chłap Z; Owsiński J
    Pol Tyg Lek; 1989 Jan 9-16; 44(2-3):63-7, 72. PubMed ID: 2678030
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pulmonary sarcoidosis simulating primary acute interstitial fibrosis at presentation. Clinical, radiologic, functional and bronchoalveolar cytologic study in 3 cases].
    Dugas M; Wallaert B; Bart F; Gosselin B; Tonnel AB; Voisin C
    Rev Mal Respir; 1989; 6(3):243-50. PubMed ID: 2740589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.